
Post-exertional malaise (PEM) is a multidimensional exertion-response pattern involving diverse triggers, variable onset, and prolonged recovery. This study developed and content-validated the Vienna Post-Exertional Malaise (VPEM) Questionnaire, a patient-reported outcome measure assessing functional decline, recovery, crash-associated symptoms, and pacing adaptations in ME/CFS. An iterative mixed-methods instrument-development study combined quantitative ratings and qualitative feedback across sequential evaluation cycles. An initial 13-item draft, informed by existing PEM, fatigue, and functional-capacity instruments and consensus literature, was evaluated by individuals with ME/CFS or Post-COVID-19 syndrome (PCS) using Likert ratings, open-ended feedback, and interviews. Quantitative data were summarised descriptively, and qualitative data were analysed using deductive–inductive structuring content analysis. Revisions were documented in revision matrices. The revised instrument was evaluated by an interdisciplinary expert panel using domain-level and item-level ratings of relevance and clarity. Twelve individuals with ME/CFS and one individual with PCS fulfilling ME/CFS criteria evaluated the questionnaire. Ratings showed high approval for length (92.3
Interpretation of patient-reported outcome measures (PROM) score changes requires knowledge of the minimally important change (MIC). The Patient-Reported Outcomes Measurement Information System Global Health questionnaire (PROMIS-GH), which contains subscales assessing physical and mental health, is increasingly used in post-stroke care. However, the MIC of the PROMIS-GH subscales has not been estimated in patients with ischemic stroke or transient ischemic attack (TIA). This study aimed to estimate the MIC of PROMIS-GH subscales in older stroke and TIA patients. This Dutch multicentre prospective cohort study included adults aged ≥ 70 years with a recent ischemic stroke or TIA (May 2024–March 2026). The PROMIS-GH was administered at baseline and after 1 month of follow-up. The MIC of the PROMIS-GH subscales was primarily estimated using the predictive modelling approach. Two additional methods, the mean change method and receiver operating characteristic analysis, were performed as secondary analyses. We included 125 patients. Ninety-five patients with a median age of 78 completed the study. Using predictive modelling, we estimated an MIC of 1.3 points for the global physical health (GPH) subscale. MIC for the global mental health (GMH) subscale could not be estimated. The MIC for the GPH subscale in older patients with ischemic stroke or TIA was small, suggesting that even small score changes may be clinically relevant in this population. No reliable MIC could be estimated for the GMH subscale, highlighting the need for further research. ClinicalTrials.gov, NCT06495073, registered on 3 July 2024.
To compare a “7-DAY” and “TODAY” recall period of the EQ-HWB-9 in people living with dementia (PlwD) with regard to day-to-day health changes (health fluctuations) and recall period adherence. In this mixed-methods study, PlwD-caregiver dyads from German primary care were randomized to complete the EQ-HWB-9 (self- and proxy-proxy report) using either a "7-day" or “today” recall period over a two-week time period on day 1, day seven and day 14. In addition, caregivers recorded daily health fluctuations over 14 days via a diary. Health fluctuations were examined in relation to EQ-HWB-9 score variability and recall adherence, which was assessed via semi-structured caregiver interviews. Quantitative analyses included recall group comparisons, effect sizes, and variance analyses. Seventy-four dyads were included (PlwD mean age 77 years; 41.9
To evaluate the long-term prognostic associations of pretreatment health-related quality of life (HRQoL) in nasopharyngeal carcinoma (NPC) and its potential incremental predictive value alongside clinical variables using explainable machine learning. This retrospective cohort included 773 patients with NPC who completed the EORTC QLQ-C30 and QLQ-H N35 before any anticancer treatment. Cox proportional hazards and machine-learning survival models were developed for overall survival (OS), locoregional recurrence-free survival (LRRFS), and distant metastasis-free survival (DMFS). Discrimination was assessed using the C-index and 10-year time-dependent AUC (TD-AUC). Shapley Additive Explanations (SHAP) were used to describe individual feature contributions to predicted risk. In separate HRQoL-domain models adjusted for baseline covariates, higher physical functioning was associated with a lower hazard of death (HR, 0.984), whereas greater swallowing impairment was associated with a higher hazard (HR, 1.017; both P < 0.001). Social eating and social contact impairments were associated with DMFS (both P < 0.05). The combined clinical-plus-HRQoL Ensemble-S model yielded an OS C-index of 0.769 and a 10-year TD-AUC of 0.812, compared with 0.737 and 0.772, respectively, for the clinical-only model. These differences were numerical; formal paired comparisons were not performed. SHAP analyses illustrated the contributions of clinical and HRQoL features to model predictions. Pretreatment HRQoL may provide complementary prognostic information in NPC. The potential incremental predictive value of HRQoL requires paired performance comparisons and external validation before clinical implementation. Doctors usually predict survival in nasopharyngeal cancer using tumor stage and laboratory tests, but these measures may not fully reflect a patient’s overall health. It is unclear whether patients’ own reports of their health-related quality of life (HRQoL) before treatment can improve long-term survival prediction. We examined whether adding pretreatment HRQoL questionnaire results to standard clinical information improves prediction of 10-year outcomes in 773 patients treated with radiotherapy. Clinical factors contributed strongly to model predictions. Adding HRQoL, particularly physical functioning and swallowing difficulties, produced numerically higher prediction accuracy. These differences were not formally tested, and the models require validation in other patient populations before use in clinical care.
To generate EQ-5D-5L population norms for adults in England using the new UK value set, and to compare, within respondents, the UK and England EQ-5D-5L value sets, the former National Institute for Health and Care Excellence (NICE) reference-case mapping, and the crosswalk. We analysed the Health Survey for England 2014 (EQ-5D-3L; n = 7,085) and 2017 (EQ-5D-5L; n = 7,169). EQ-5D-5L responses were scored with both value sets and converted to the UK EQ-5D-3L value set using the mapping and the crosswalk. Agreement was assessed against a prespecified equivalence margin of 0.030, and differences decomposed by dimension. Mean index scores were 0.867 (SD 0.223) under the UK EQ-5D-3L value set, and 0.891 (SD 0.206) and 0.885 (SD 0.187) under the UK and England EQ-5D-5L value sets. The latter two were equivalent at the population level (mean difference 0.006, 90